Marinus Pharmaceuticals ROE Ratio 2011-2026 | MRNS

Annual ROE Ratio Marinus Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-843.45	-17.08	-184.68	-49.18	-61.66	-53.75	-32.58	-133.35	-52.96	-26.32	-55.72	-33.68	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-17.08	-843.45	-128.7

Quarterly ROE Ratio Marinus Pharmaceuticals

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
286.81	190.06	58.69	-156.97	-67.6	82.24	-683.08	-779.55	-804.4	-918.63	-122.68	-73.45	-84.86	-71.42	-57.78	-36.45	-62.32	-74.08	-83.51	-90.85	-79.79	-72.87	-65.93	-53.75	-47.12	-38.05	-31.98	-32.58	-52.41	-75.32	-109.13	-133.35	-121.57	-102.05	-71.62	-52.96	-45.51	-38.99	-35.83	-26.32	-15.25	-9.17	1.69	7.12	4.81	2.79	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
286.81	-918.63	-105.33

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	-32.19	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	-294.78	-	10.36 %	$ 9.8 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
Avenue Therapeutics ATXI	-158.79	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Axcella Health AXLA	-1949.71	-	-16.42 %	$ 249 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	-108.93	-	-	$ 546 M	USA
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
Brickell Biotech BBI	-57.34	-	-5.38 %	$ 6.06 M	USA
Atreca BCEL	-123.92	-	-11.76 %	$ 5.79 M	USA
CASI Pharmaceuticals CASI	-43.38	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
ChemoCentryx CCXI	-46.05	-	-	$ 3.74 B	USA
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Завод ДИОД DIOD	3.1	-	-	-	Russia
Фармсинтез LIFE	-51.75	-	-	-	Russia
Bellerophon Therapeutics BLPH	-782.6	-	-74.18 %	$ 955 K	USA
Chimerix CMRX	-42.53	-	-	$ 756 M	USA
Teligent, Inc. TLGT	473.41	-	-13.85 %	$ 16.1 M	USA
AbbVie ABBV	-55.54	$ 208.7	-0.07 %	$ 369 B	USA
Calithera Biosciences CALA	-1373.04	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-86.96	-	-3.03 %	$ 260 M	USA
Viela Bio, Inc. VIE	-40.09	-	-	$ 2.91 B	USA
AbCellera Biologics ABCL	-15.14	$ 3.52	-0.14 %	$ 1.05 B	Canada